Universal Ibogaine Inc.
IBO.V
TSX
04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
---|---|---|---|---|---|
Net Income | -76.87% | 72.02% | 75.80% | 93.38% | 61.22% |
Total Depreciation and Amortization | 11.05% | 17.67% | 23.90% | 7.15% | -5.49% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 762.58% | -92.65% | -86.08% | -95.74% | 0.63% |
Change in Net Operating Assets | -145.85% | 578.33% | -131.93% | 108.48% | -37.29% |
Cash from Operations | -190.64% | 85.87% | 59.88% | 100.32% | 78.95% |
Capital Expenditure | 55.06% | 95.65% | 66.72% | 402.20% | 52.27% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 55.06% | 95.65% | 66.72% | -94.16% | 52.27% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -697.56% | -86.71% | -74.89% | 76.54% | 98.49% |
Issuance of Common Stock | -- | -- | -81.46% | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 66.21% | 56.56% | -88.33% | 34.85% | 229.36% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -34.57% | 139.91% | -571.43% | 96.88% | 113.44% |